Rationality of Anti-Tuberculosis Drug (OAT) Use in Pulmonary Tuberculosis Patients at Kediri District Hospital in 2025
DOI:
https://doi.org/10.55927/modern.v5i3.46Keywords:
Anti-Tuberculosis Drugs, Rationality, Pulmonary TuberculosisAbstract
Tuberculosis is a contagious infection that primarily affects the lungs and is caused by the bacteria Mycrobacterium tuberculosis. The purpose of this study was to determine the rationality of using anti-tuberculosis drugs (OAT) in pulmonary tuberculosis patients at Kediri District Hospital in 2025. This study uses an observational method with a retrospective descriptive design based on medical record data of tuberculosis patients at Kediri District Hospital in 2025. The sampling technique used was purposive sampling which was in accordance with the inclusion criteria. This study was conducted in February 2026 with a sample of 62 patients. The collected data were then analyzed descriptively using univariate analysis, and the results were presented in the form of frequency distributions and percentages. The results of the study showed that the rationality of OAT use in tuberculosis patients was achieved by correct patient (100%), correct indication (100%), correct medication selection (96.77%), correct dose (95.16%), correct duration of medication administration (98.39%), and correct method of medication administration (100%). Conclusion: This indicates that pulmonary tuberculosis treatment is in accordance with treatment guidelines
References
Arisandi, D., Sugiarti, W., & Islamarida, R. (2023). Karakteristik Penderita Tuberkulosis Paru di Kabupaten Sleman, D.I.Yogyakarta. Jurnal Formil (Forum Ilmiah) KesMas Respati Vol., 8(1), 64–69. http://formilkesmas.respati.ac.id
Azizah, I. (2020). Determinan Lama Waktu Kesembuhan pada Pengobatan Pasien Tuberkulosis Kategori I. Higeia Journal of Public Health Research and Development, 4(3), 574–583. https://doi.org/https://doi.org/10.15294 /higeia.v4iSpecial%203/ 34565
Bakhtiar, M. I., Wiedyaningsih, C., Yasin, N. M., & Kristina, S. A. (2021). Hubungan Karakteristik, Kepatuhan, dan Outcome Klinis Pasien Tuberkulosis Paru di Puskesmas Kabupaten Bantul. Majalah Farmasetik, 17(2), 256–269. https://doi.org/10.22146/farmaseutik.v17i2.60681
Bayan, U. A.-Q., Prihanto, E. S. D., & Anwar, M. (2022). Karakteristik Pasien Tuberkulosis Resistan Obat di RSUD Dr. H. Chasan Boesoirie. Kieraha Nedical Journal, 4(1), 15–21. https://ejournal.unkhair.ac.id/index.php/kmj
Fauziah, D. W., Mulyani, E., & Yanti, S. (2022). Evaluasi Rasionalitas Penggunaan Obat Anti Tuberkulosis (OAT) di salah satu Rumah Sakit di Bengkulu Periode 2021. Jurnal Farmasi Malahayati, 5(2), 203–209.
Fraga, A. D. S. S., Oktavia, N., & Mulia, R. A. (2021). Evaluasi Penggunaan Obat Anti Tuberkulosis Pasien Baru Tuberkulosis Paru di Puskesmas Oebobo Kupang Tahun 2020. Jurnal Farmagazine, VIII(1), 17–24. https://doi.org/http://dx.doi.org/10.47653/farm.v8i1.530
Gotera, W., Nugraha, I. B. A., & Yustin, W. E. F. (2021). Diabetes Melitus sebagai Faktor Risiko Tuberkulosis. Jurnal Kedokteran MEDITEK, 27(3), 273–281. https://doi.org/https://doi.org/10.36452/jkdoktmeditek.v27i3.2126
Kasni, Hanafi, L. O. A., Fauziah, R., & Yuliastri, W. O. (2024). Rasionalitas Penggunaan Obat Anti Tuberkulosis Pada Pasien Tuberkulosis Paru Di Puskesmas Poasia Kota Kendari Tahun 2021. Jurnal Pharmacia Mandala Waluya, 3(1), 1–11. https://doi.org/https://doi.org/10.54883/jpmw.v3i1.88
Kementerian Kesehatan, R. I. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis.
Kementerian Kesehatan, R. I. (2021). Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024 (II, pp. 1–223).
Menteri Kesehatan, R. I. (2019). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/755/2019 Tentang pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis (pp. 1–139).
Nababan, H., Hidayat, W., Sitorus, M. E. J., & Brahmana, N. (2022). Strategi Dots Dalam Program Penanggulangan Tuberkulosis di Puskesmas Matiti Kecamatan Doloksanggul Kabupaten Humbang Hasundutan. PREPOTIF Jurnal Kesehatan Masyarakat, 6(3), 1902–1918.
PDPI. (2021). Tuberkulosis Pedoman Diagnosis dan Penatalaksanan di Indonesia. Perhimpunan Dokter Paru Indonesia.
Riskesdas. (2018). Laporan Nasional Riskesdas 2018 (BALITBANGKES (ed.)). Badan Penelitian Dan Pengembangan Kesehatan.
SKI. (2023). Survei Kesehatan Indonesia (SKI) Tahun 2023.
WHO. (2022). Global Tuberculosis Report 2022.
